FDA Approves Unknown Drug — SANDOZ
Sandoz announced late Tuesday that its ANDA submission for the New Drug Application, ANDA075428, received FDA approval on January 24. This clearance is expected to broaden market accessibility for the relevant formulation, challenging the status quo for branded treatments in this therapeutic class.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed